Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Atyr Pharma Inc (ATYR)

111 + Investors. Track Smart Money conviction in ATYR. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +27
Streak
1Q ▲
Buyers last Q
61%

Smart Money Signals — ATYR

Based on 112 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ATYR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (99% of max)

99% of all-time peak
112 hedge funds hold ATYR right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +29% more funds vs a year ago

fund count last 6Q
+25 new funds entered over the past year (+29% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 61% buying

66 buying42 selling
Last quarter: 66 funds were net buyers (38 opened a brand new position + 28 added to an existing one). Only 42 were sellers (31 trimmed + 11 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+20 vs last Q)

new funds entering per quarter
Funds opening a new ATYR position: 52 → 43 → 18 → 38. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 29% long-term, 45% new

■ 29% conviction (2yr+) ■ 27% medium ■ 45% new
Of the 112 current holders: 32 (29%) held >2 years, 30 held 1–2 years, and 50 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +4%, value -22%

Value
-22%
Shares
+4%
Last quarter: funds added +4% more shares while total portfolio value only changed -22%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

26 → 52 → 43 → 18 → 38 new funds/Q
New funds entering each quarter: 52 → 43 → 18 → 38. ATYR is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🌱

Early stage — 59% of holders entered in last year

■ 37% veterans ■ 4% 1-2yr ■ 59% new
Of 119 current holders: 70 (59%) entered in the past year, only 44 (37%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 53% AUM from top-100 funds

53% from top-100 AUM funds
36 of 110 holders are among the 100 largest funds by AUM, controlling 53% of total institutional value in ATYR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ATYR

In 2026 Q1, 66 hedge funds were net buyers of ATYR (38 opened a new position, 28 added to an existing one), while 42 reduced or exited (31 trimmed, 11 sold completely) — a 61% buyer ratio, indicating clear institutional accumulation. 53% of total institutional value in ATYR is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +27 funds (more new holders than closures). Total institutional holders: 112.

Hedge Fund Ownership: ATYR

How many hedge funds hold ATYR — quarterly history vs. share price
Quarterly hedge fund ownership of ATYR vs. share price

Market Analysis: ATYR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ATYR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Atyr Pharma Inc (ATYR) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ATYR has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
ATYR
-43.6%
XLV
+4.9%

ATYR outperformed XLV by -48.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
ATYR
-15.4%
XLV
+6.0%

Since the filing became public, ATYR outperformed XLV by -21.4% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

13 top-rated funds 0 high-conviction
Consensus
5.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: ATYR
111 + Investors

Track Smart Money conviction in ATYR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 111 85 30.59%
13F Shares 58M 56M 4.24%
Total Value $44M $57M -22.44%
New Positions 37 18 +19
Increased Positions 26 20 +6
Closed Positions 11 46 -35
Reduced Positions 30 28 +2
Total Calls 5 5 -
Total Puts 4 4 -
PUT/CALL Ratio 0.8 0.8 Neutral

Statistics: ATYR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

111 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ATYR. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ATYR holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Federated Hermes, INC. 0.01% 10,509,678 $8.2M
2 Hohimer Wealth Management, LLC 0.01% 100,000 $78K
3 EverSource Wealth Advisors, LLC 0.01% 580,723 $219K
4 Hobbs Group Advisors, LLC 0.00% 19,419 $15K
5 Redhawk Wealth Advisors, Inc. 0.00% 49,150 $38K
6 My Portfolio Guide, LLC 0.00% 7,000 $5K
7 ADAR1 Capital Management, LLC 0.00% 50,685 $40K
8 Kingswood Wealth Advisors, LLC 0.00% 52,000 $41K
9 Diadema Partners LP 0.00% 12,500 $10K
10 Diadema Partners LP 0.00% 12,200 $10K
11 XTX Topco Ltd 0.00% 111,423 $87K
12 Ares Financial Consulting, LLC 0.00% 2,000 $2K
13 Pasadena Private Wealth, LLC 0.00% 12,228 $10K
14 Belpointe Asset Management LLC 0.00% 45,738 $36K
15 Two Sigma Advisers, LP 0.00% 841,350 $659K
16 Trust Co of Toledo NA /Oh/ 0.00% 16,640 $13K
17 RBF Capital, LLC 0.00% 20,000 $16K
18 Two Sigma Investments, LP 0.00% 1,144,565 $893K
19 Fmr LLC 0.00% 14,706,843 $11.5M
20 Millennium Management LLC 0.00% 1,641,246 $1.3M
21 UBS Group AG 0.00% 3,867,213 $3.0M
22 Essential Partners LLC 0.00% 1,618 $1K
23 Tower Research Capital LLC (TRC) 0.00% 17,426 $14K
24 Vision Retirement, LLC 0.00% 1,500 $1K
25 Gladstone Institutional Advisory LLC 0.00% 11,300 $9K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Atyr Pharma Inc (ATYR)

What does the Smart Money Trend signal show for ATYR?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ATYR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ATYR?

More buyers than sellers — 61% buying: Last quarter: 66 funds were net buyers (38 opened a brand new position + 28 added to an existing one). Only 42 were sellers (31 trimmed + 11 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ATYR holders?

Elite ownership — 53% AUM from top-100 funds: 36 of 110 holders are among the 100 largest funds by AUM, controlling 53% of total institutional value in ATYR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ATYR?

Mixed — 29% long-term, 45% new: Of the 112 current holders: 32 (29%) held >2 years, 30 held 1–2 years, and 50 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Atyr Pharma Inc (ATYR) following the 2026 Q1 hedge fund 13F filings?

As of today, ATYR has moved -15.4% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -21.4%. Since the quarter end (March 31, 2026), ATYR has gained -43.6% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →